Management of Candida infections in the adult intensive care unit

Expert Opinion on Pharmacotherapy
Mario Cruciani, Giovanni Serpelloni

Abstract

The epidemiology of Candida infection in intensive care units (ICUs) and the management strategies for such infections in non-neutropenic intensive care patients are discussed in this review. Candida species are one of the leading causes of nosocomial bloodstream infections and a significant cause of morbidity in patients admitted to the ICU. Prophylactic, pre-emptive and empiric treatment strategies for Candida infections have been explored in ICU patients. Routine prophylaxis should not be administered to the whole population of ICU patients, because the concerns about the selection of azole-resistant Candida strains or the induction of resistance are justified. Treatment of fungal infections is now possible with newer antifungal agents, including newer azoles (e.g., voriconazole, posaconazole) and echinocandins (e.g., micafungin, anidulafungin). However, there is a critical need for improvement in diagnosis of invasive Candida infection in order to provide clinicians the opportunity to intervene earlier in the diseases course.

References

Mar 1, 1992·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·G P Bodey
Oct 1, 1989·Archives of Internal Medicine·S B WeyR P Wenzel
Jan 1, 1995·Antimicrobial Agents and Chemotherapy·J H RexM A Pfaller
Mar 1, 1996·Archives of Surgery·V J Henderson, E R Hirvela
Aug 1, 1996·Journal of Clinical Microbiology·K MitsutakeS Kohno
Oct 1, 1996·Clinical Microbiology Reviews·S K Fridkin, W R Jarvis
Jan 1, 1996·The Indian Journal of Medical Research·K Satyanarayana, N Medappa
May 1, 1997·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·P PhillipsS Ioannou
Aug 2, 1997·BMJ : British Medical Journal·J Lipman, R Saadia
Feb 13, 1999·Journal of Clinical Microbiology·Y F BerrouaneM A Pfaller
Aug 25, 1999·Diagnostic Microbiology and Infectious Disease·A L ColomboS B Wey
Sep 7, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M B EdmondR P Wenzel
Sep 7, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M S Rangel-FraustoR P Wenzel
Jan 5, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J D SobelW E Dismukes
Apr 19, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J H RexJ E Edwards
Apr 19, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M S SaagW E Dismukes
Feb 15, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J H RexJ E Edwards
Mar 16, 2001·Expert Opinion on Pharmacotherapy·R Patel
Mar 16, 2001·Expert Opinion on Pharmacotherapy·G E PiérardC Piérard-Franchimont
Apr 3, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J H Rex, J D Sobel
Jun 13, 2001·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Y KrupovaV Krcmery
Jun 22, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·H M BlumbergUNKNOWN National Epidemiology of Mycoses Survey(NEMIS) Study Group
Jun 22, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J D Sobel, J H Rex
Oct 5, 2001·Expert Opinion on Pharmacotherapy·G J Wise
Dec 4, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S AsciogluUNKNOWN Mycoses Study Group of the National Institute of Allergy and Infectious Diseases
Dec 26, 2001·The Journal of Antimicrobial Chemotherapy·A P Fraise
Jan 5, 2002·The New England Journal of Medicine·D KaufmanL G Donowitz
Jan 22, 2002·The Journal of Antimicrobial Chemotherapy·David A Stevens
Jan 25, 2002·The New England Journal of Medicine·Thomas J WalshUNKNOWN National Institute of Allergy and Infectious Diseases Mycoses Study Group

❮ Previous
Next ❯

Citations

Apr 2, 2013·The Journal of Antimicrobial Chemotherapy·Fengmei GuoUNKNOWN China-SCAN Team
Sep 10, 2008·Drugs·Maria J G T RüpingOliver A Cornely
Mar 19, 2014·Burns : Journal of the International Society for Burn Injuries·Eirini LiodakiFelix Stang
May 12, 2009·Expert Opinion on Investigational Drugs·Maria J G T RuepingOliver A Cornely
Sep 11, 2013·Journal of Critical Care·George DimopoulosJean-Louis Vincent
Apr 21, 2009·Clinics in Chest Medicine·L Joseph Wheat
Dec 22, 2016·Revista Da Sociedade Brasileira De Medicina Tropical·Remzi ÇevikMehmet Gem
Jul 3, 2018·Virulence·Shuying XuMichael K Mansour
Jun 23, 2009·Psychotherapy Research : Journal of the Society for Psychotherapy Research·Howard SteeleAnne Murphy
Feb 26, 2010·Psychotherapy Research : Journal of the Society for Psychotherapy Research·William B Stiles
Jun 18, 2017·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Y WangY Dong

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.